Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion

Molecular Cell

Volumn 3, Issue 5, 1999, Pages 565-577

  Pelengaris, Stella ^a,b   Littlewood, Trevor ^a   Khan, Michael ^a   Elia, George ^a   Evan, Gerard ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; VASCULOTROPIN;

ACTINIC KERATOSIS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE C MYC; PAPILLOMATOSIS; PRECANCER; PROTO ONCOGENE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0033001621     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80350-0     Document Type: Article

References (58)

1. Amati, B., and Land, H. (1994). Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev. 4, 102-108.
2. Askew, D.S., Ashmun, R.A., Simmons, B.C., and Cleveland, J.L. (1991). Constitutive c-myc expression in an IL-3-de pendent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915-1922.
3. Ayer, D.E., and Eisenman, R.N. (1993). A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte macrophage differentiation. Genes Dev. 7, 2110-2119.
4. Bates, R.C., Buret, A., van Helden, D.F., Horton, M.A., and Burns, G.F. (1994). Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125, 403-415.
5. Bello-Fernandez, C., Packham, G., and Cleveland, J.L. (1993). The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90, 7804-7808.
6. Ben-Yosef, T., Yanuka, O., Halle, D., and Benvenisty, N. (1998). Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene 17, 165-171.
7. Campbell, C., Quinn, A.G., Ro, Y.S., Angus, B., and Rees, J.L. (1993). p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J. Invest. Dermatol. 100, 746-748.
8. Carroll, J.M., Albers, K.M., Garlick, J.A., Harrington, R., and Taichman, L.B. (1993). Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. Proc. Natl. Acad. Sci. USA 90, 10270-10274.
9. Cotsarelis, G., Sun, T.T., and Lavker, R.M. (1990). Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61, 1329-1337.
10. Downward, J. (1998). Ras signaling and apoptosis. Curr. Opin. Genet. Dev. 8, 49-54.
11. Eilers, M., Picard, D., Yamamoto, K.R., and Bishop, J.M. (1989). Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340, 66-68.
12. Evan, G., and Littlewood, T. (1998). A matter of life and cell death. Science 287, 1317-1322.
13. Evan, G.I., and Littlewood, T.D. (1993). The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3, 44-49.
14. Evan, G.I., Lewis, G.K., Ramsay, G., and Bishop, J.M. (1985). Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5, 3610-3616.
15. Evan, G., Wyllie, A., Gilbert, C., Littlewood, T., Land, H., Brooks, M., Waters, C., Penn, L., and Hancock, D. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 63, 119-125.
16. Fuchs, E. (1990). Epidermal differentiation: the bare essentials. J. Cell Biol. 111, 2807-2814.
17. Fuchs, E. (1992). Genetic skin disorders of keratin. J. Invest. Dermatol. 99, 671-674.
18. Gandarillas, A., and Watt, F.M. (1997). c-Myc promotes differentiation of human epidermal stem cells. Genes Dev. 11, 2869-2882.
19. Hanahan, D., and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
20. Hermiston, M.L., and Gordon, J.I. (1995). In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J. Cell Biol. 129, 489-506.
21. Hsu, B., Marin, M.C., el-Naggar, A.K., Stephens, L.C., Brisbay, S., and McDonnell, T.J. (1995). Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene 11, 175-179.
22. Hurlin, P.J., Foley, K.P., Ayer, D.E., Eisenman, R.N., Hanahan, D., and Arbeit, J.M. (1995). Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11, 2487-2501.
23. Jin, Y., Burns, F.J., and Garte, S.J. (1992). Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats. Radiat. Res. 132, 193-199.
24. Johnson, L.D., Idler, W.W., Zhou, X.M., Roop, D.R., and Steinert, P.M. (1985). Structure of a gene for the human epidermal 67-kDa keratin. Proc. Natl. Acad. Sci. USA 82, 1896-1900.
25. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P.H., and Downward, J. (1997). Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B Akt cellular survival pathway. EMBO J., 16, 2783-2793.
26. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
27. Larsson, L.G., Pettersson, M., Oberg, F., Nilsson, K., and Luscher, B. (1994). Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 9, 1247-1252.
28. Littlewood, T., Hancock, D., Danielian, P., Parker, M., and Evan, G. (1995). A modified estrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23, 1686-1690.
29. Marks, R., Rennie, G., and Selwood, T.S. (1988). Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 7, 795-797.
30. Martin, P. (1997). Wound healing-aiming for perfect skin regeneration. Science 276, 75-81.
31. Moore, J.P., Hancock, D.C., Littlewood, T.D., and Evan, G.I. (1987). A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res. 2, 65-80.
32. Morgenbesser, S.D., and DePinho, R.A. (1994). Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin. Cancer Biol. 5, 21-36.
33. Morgenbesser, S.D., Schreiber-Agus, N., Bidder, M., Mahon, K.A., Overbeek, P.A., Horner, J., and DePinho, R.A. (1995). Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBO J. 14, 743-756.
34. Morris, R.J. (1994). Procedure for harvesting epidermal cells from the dorsal epidermis of adult mice for primary cell culture in "high calcium" defined medium. In Keratinocyte Methods, I.M. Leigh and P.M. Watt, eds. (Cambridge: Cambridge University Press), pp. 25-31.
35. Nelson, W.G., and Sun, T.T. (1983). The 50- and 58-kD keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J. Cell Biol. 97, 244-251.
36. O'Brien, T.G., Megosh, L.C., Gilliard, G., and Soler, A.P. (1997). Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res. 57, 2630-2637.
37. Packham, G., and Cleveland, J.L (1994). Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol. Cell Biol. 14, 5741-5747.
38. Packham, G., and Cleveland, J.L. (1995). The role of ornithine decarboxylase in c-Myc-induced apoptosis. Curr. Top. Microbiol. Immunol. 794, 283-290.
39. Pelisson, I., Soler, C., Pechoux, C., Chignol, M.C., Viac, J., Euvrard, S., and Chardonnet, Y. (1992). c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions. J. Dermatol. Sci. 3, 56-67.
40. Poulsom, R., Longcroft, J.M., Jeffery, R.E., Rogers, L.A., and Steel, J.H. (1998). A robust method for isotopic riboprobe in situ hybridisation to localise mRNAs in routine pathology specimens. Eur. J. Histochem. 42, 121-132.
41. Quinn, A.G. (1997). Ultraviolet radiation and skin carcinogenesis. Br. J. Hosp. Med. 58, 261-264.
42. Rees, J. (1994). Genetic alterations in non-melanoma skin cancer. J. Invest. Dermatol. 103, 747-750.
43. Rieger, M., and Franke, W.W. (1988). Identification of an orthologous mammalian cytokeratin gene. High degree of intron sequence conservation during evolution of human cytokeratin 10. J. Mol. Biol. 204, 841-856.
44. Sakamuro, D., Eviner, V., Elliott, K.J., Showe, L., White, E., and Prendergast, G.C. (1995). c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11, 2411-2418.
45. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Second Edition (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
46. Sandgren, E.P., Quaife, C.J., Pinkert, C.A., Palmiter, R.D., and Brinster, R.L. (1989). Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4, 715-724.
47. Sawey, M.J., Hood, A.T., Burns, F.J., and Garte, S.J. (1987). Activation of c-myc and c-K-rasoncogenes in primary rat tumors induced by ionizing radiation. Mol. Cell. Biol. 7, 932-935.
48. Schluter, C., Duchrow, M., Wohlenberg, C., Becker, M.H., Key, G., Flad, H.D., and Gerdes, J. (1993). The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol. 123, 513-522.
49. Schwartz, R.A. (1996). Premalignant keratinocytic neoplasms. J. Am. Acad. Dermatol. 35, 223-242.
50. Smith-McCune, K., Zhu, Y.H., Hanahan, D., and Arbeit, J. (1997). Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res. 57, 1294-1300.
51. Stoler, A., Kopan, R., Duvic, M., and Fuchs, E. (1988). Use of mono-specific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J. Cell Biol. 107, 427-446.
52. Suarez, H.G. (1989). Activated oncogenes in human tumors. Anticancer Res. 9, 1331-1343.
53. Tennenbaum, T., Weiner, A.K., Belanger, A.J., Glick, A.B., Hennings, H., and Yuspa, S.H. (1993). The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Res. 53, 4803-4810.
54. Trudel, M., Lanoix, J., Barisoni, L., Blouin, M.J., Desforges, M., L'Italien, C., and D'Agati, V. (1997). C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J. Exp. Med. 186, 1873-1884.
55. Tyner, A.L., and Fuchs, E. (1986). Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis. J. Cell Biol. 103, 1945-1955.
56. Weeks, C.E., Herrmann, A.L., Nelson, F.R., and Slaga, T.J. (1982). alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc. Natl. Acad. Sci. USA 79, 6028-6032.
57. Woodcock-Mitchell, J., Eichner, R., Nelson, W.G., and Sun, T.T. (1982). Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J. Cell Biol. 95, 580-588.
58. Zervos, A.S., Gyuris, J., and Brent, R. (1993). Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72, 223-232.